344159 <common-name>N-(5-acetamido-2-methoxyphenyl)-2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-(5-acetamido-2-methoxyphenyl)-2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C26H24ClN5O4S. With an average molecular weight of 538.00 g/mol, N-(5-acetamido-2-methoxyphenyl)-2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>476484-35-2</cas> <pubchem-id>1544121</pubchem-id> <chemical-formula>C26H24ClN5O4S</chemical-formula> <weight>538</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T05:59:44Z</created-at> <updated-at type="dateTime">2026-08-31T05:59:44Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=O)NC1=CC(=C(C=C1)OC)NC(=O)CSC2=NN=C(N2C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OC</moldb-smiles> <moldb-formula>C26H24ClN5O4S</moldb-formula> <moldb-inchi>InChI=1S/C26H24ClN5O4S/c1-16(33)28-19-8-13-23(36-3)22(14-19)29-24(34)15-37-26-31-30-25(17-4-11-21(35-2)12-5-17)32(26)20-9-6-18(27)7-10-20/h4-14H,15H2,1-3H3,(H,28,33)(H,29,34)</moldb-inchi> <moldb-inchikey>RWPPCOCIQHYDIO-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">537.1237531</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM340052</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-(5-acetamido-2-methoxyphenyl)-2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0294532</sync-id> <structure-inchikey>RWPPCOCIQHYDIO-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800200000800000000000000008100000080004004400000000000000000200004008000002080000000000000000000000000200000000020040000400000000000000000000020000000000100000200000010000000040000010080010050400000100000800000000100000000000000000000400000000060020000000000000000000080880000010000000080000000000000000000000000000000000000080000000000000000410000000000002c00000080000000000000000000000000000000000010000000002000000200000000000000008040000000000040000000000400000008010020000040000000020000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGACgAAAAD BAgAKAAAAAMCBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCAAoAAAAAwIGAGAAAAABAwcAaAAA AAMCAQYAKAAAAAMECAAoAAAAAwIGAGAAAAACAhAAIAAAAAIGQCgAAAADBAdA KAAAAAMDB0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAAD AwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAREAIAAAAAEG QCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBo AAAAAwMBCAAoAAAAAwIGAGAAAAABAwsAAQABAigCAQMgAwQgBAVoDAUGaAwG B2gMBwhoDAgJaAwHCiAKCwAGDCAMDSANDigCDQ8ADxAAEBEAERJoDBITaAwT FGgMFBVoDBUWIBYXaAwXGGgMGBloDBkaaAwaG2gMGRwAFB0gHR5oDB4faAwf IGgMICFoDCEiaAwgIyAjJAAJBGgMFRFoDBsWaAwiHWgMQgQAAAAGBAkIBwYF BRIRFRQTBhcYGRobFgYeHyAhIh0XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:43:27Z</structure-indexed-at> </compound>